171 related articles for article (PubMed ID: 6778941)
21. Structure and function of factor VIII procoagulant protein.
Fulcher CA; Zimmerman TS
Prog Clin Biol Res; 1984; 150():57-71. PubMed ID: 6431442
[No Abstract] [Full Text] [Related]
22. Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor).
Beck EA; Bachmann P; Barbier P; Furlan M
Thromb Haemost; 1976 Feb; 35(1):186-90. PubMed ID: 1085500
[TBL] [Abstract][Full Text] [Related]
23. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.
Fulcher CA; Gardiner JE; Griffin JH; Zimmerman TS
Blood; 1984 Feb; 63(2):486-9. PubMed ID: 6419799
[TBL] [Abstract][Full Text] [Related]
24. Thrombin activation of factor VIII. II. A comparison of purified factor VIII and the low molecular weight factor VIII procoagulant.
Rick ME; Hoyer LW
Br J Haematol; 1978 Jan; 38(1):107-19. PubMed ID: 638056
[TBL] [Abstract][Full Text] [Related]
25. [Procoagulant properties of beta/gamma-thrombin].
Semenova OA; Strukova SM
Vopr Med Khim; 1982; 28(4):137-40. PubMed ID: 6810543
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex.
Fuentes-Prior P; Iwanaga Y; Huber R; Pagila R; Rumennik G; Seto M; Morser J; Light DR; Bode W
Nature; 2000 Mar; 404(6777):518-25. PubMed ID: 10761923
[TBL] [Abstract][Full Text] [Related]
27. Proteolytic activity of alpha 2-macroglobulin-enzyme complexes toward human factor VIII/von Willebrand factor.
Switzer ME; Gordon HJ; McKee PA
Biochemistry; 1983 Mar; 22(6):1437-44. PubMed ID: 6188490
[TBL] [Abstract][Full Text] [Related]
28. [Factor VIII complex activities in acute leukemia].
Pniejnia-Olszyński W; Lopaciuk S
Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.
Eaton D; Rodriguez H; Vehar GA
Biochemistry; 1986 Jan; 25(2):505-12. PubMed ID: 3082357
[TBL] [Abstract][Full Text] [Related]
30. Dissociation of factor VIII in the presence of proteolytic inhibitors.
Sussman II; Weiss HJ
Thromb Haemost; 1978 Oct; 40(2):316-25. PubMed ID: 310586
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
Over J; Bouma BN; Sixma JJ; Bolhuis PA; Vlooswijk RA
J Lab Clin Med; 1980 Mar; 95(3):323-34. PubMed ID: 7354239
[TBL] [Abstract][Full Text] [Related]
32. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
Johnson DJ; Pemberton S; Acquila M; Mori PG; Tuddenham EG; O'Brien DP
Thromb Haemost; 1994 Apr; 71(4):428-33. PubMed ID: 8052958
[TBL] [Abstract][Full Text] [Related]
33. Thrombin proteolysis of purified factor viii procoagulant protein: correlation of activation with generation of a specific polypeptide.
Fulcher CA; Roberts JR; Zimmerman TS
Blood; 1983 Apr; 61(4):807-11. PubMed ID: 6403080
[TBL] [Abstract][Full Text] [Related]
34. The action of immobilized thrombin on factor VIII, fibrinogen and a synthetic tripeptide.
Brown JE; Carton CL; Dietz AS; Baugh RF; Hougie C
Thromb Haemost; 1978 Aug; 40(1):144-51. PubMed ID: 569372
[TBL] [Abstract][Full Text] [Related]
35. Antihaemophilic factor (factor VIII) from human granulocytes.
Szmitkowski M; Prokopowicz J; Szmitkowska K
Haematologia (Budap); 1977; 11(1-2):177-87. PubMed ID: 27427
[TBL] [Abstract][Full Text] [Related]
36. Factor VIII and human platelet aggregation. IV. Effect of proteolytic enzymes on platelet aggregation by factor VIII.
Vermylen J; Bottecchia D
Br J Haematol; 1976 Oct; 34(2):331-40. PubMed ID: 135576
[TBL] [Abstract][Full Text] [Related]
37. The influence of thrombin on the clotting activity of factor VIII. A study with insolubilized thrombin.
Vukovich T; Koller E; Doleschel W
Thromb Haemost; 1978 Jun; 39(3):600-6. PubMed ID: 705688
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of human Factor VIII by granulocyte proteases.
Váradi K; Marossy K; Asbóth G; Elödi P; Elödi S
Thromb Haemost; 1980 Feb; 43(1):45-8. PubMed ID: 6773173
[TBL] [Abstract][Full Text] [Related]
39. The size of human factor VIII heterodimers and the effects produced by thrombin.
Fay PJ; Anderson MT; Chavin SI; Marder VJ
Biochim Biophys Acta; 1986 Jun; 871(3):268-78. PubMed ID: 3085715
[TBL] [Abstract][Full Text] [Related]
40. Rabbit factor VIII: identification of size heterogeneity.
Rick ME; Wampler DE; Hoyer LW
Blood; 1977 Feb; 49(2):209-17. PubMed ID: 831874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
